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Purpose: Extensive extirpation of cervico-mediastinal
adipose tissue increases the chance of removing ectopic thymic
tissues, thus potentially improving the prognosis of myasthenia
gravis after thymectomy. We sought to increase efficacy and
safety of transsternal maximal thymectomy (TSMT). Materials
and Methods: Twenty four patients who underwent TSMT from
July 2006 to June 2007 were retrospectively reviewed and
compared with 73 patients who underwent transsternal ex-
tended thymectomy (TSET) from January 2004 to May 2006.
Ectopic thymic tissue in additionally excised cervicomedi-
astinal fat tissue was examined histologically. Results: In
TSMT group, operation time, amount of cumulative drainage and
duration of drainage were significantly higher than TSET group.
However, the difference in hemoglobin count, amount of trans-
fusion, duration of intensive care, postoperative hospital stay,
and complication rates were not statistically different. There was
no operative mortality in either group. Ectopic thymic tissue was
found in 50% of patients. All patients had ectopic thymic tissues
in the cervical area. Two patients had additional ectopic tissue
in the aortopulmonary window, and 1 patient had ectopic tissue
at posterior of the left bracheocephalic vein and lateral of the
right phrenic nerve. Conclusion: TSMT is more effective in the
extirpation of ectopic thymic tissues than TSET without signifi-
cant impairment of safety, especially in the cervical area.
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INTRODUCTION
Thymectomy is an important and reliable treat-
ment modality for myasthenia gravis (MG).1,2
However, the route of approach and extent of
thymectomy vary.3-7 Theoretically, a more ex-
tended resection of cervico-mediastinal adipose
tissue increases the chances of ectopic thymic
tissue removal, thus increasing the chance of
remission from myasthenic symptoms.7-9 A maximal
thymectomy is the most extensive method for ex-
tirpation of cervical and mediastinal adipose tissue
with ectopic thymic tissue.3,8 Although Jaretzki and
colleagues reported excellent long term prognosis
with this technique, maximal thymectomy is still
reported to be undertaken in a minority of cases
of thymectomy in the literature. Since June 2006,
the authors performed transsternal maximal
thymectomy (TSMT) and considered it the pro-
cedure of choice for the treatment of MG, ex-
pecting improved neurologic outcomes over those
of transsternal extended thymectomy (TSET).
TSMT is a modification of transcervical transster-
nal maximal thymectomy, and cervical extirpation
is performed beneath the retracted cervical skin
and strap muscles without a separate cervical
incision.
10
We intended to evaluate the efficacy and
feasibility of TSMT for the removal of ectopic
thymic tissue through a histologic evaluation of
ectopic thymic tissue in the cervico-mediastinal
adipose tissue.
MATERIALS AND METHODS
Twenty-four patients with MG who underwent
TSMT from July 2006 to June 2007 were retrospec-
tively compared with 73 patients who underwent
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TSET from January 2004 to June 2006. MG was
diagnosed using the anticholinesterase test and
electromyography. All patients were managed by
2 attending neurologists. All thymectomies were
conducted through a median sternotomy. Borders
of the TSET were the same as previously reported.5
In the case of TSMT, additional dissection of
adipose tissues was performed at the aortopul-
monary window, at lateral of both phrenic nerves
from phrenic nerve to both pleural reflections, in
the cervical area between both recurrent laryngeal
nerves from the lower border of thyroid to the
upper border of the right brachiocephalic artery,
and posterior to the left brachiocephalic vein.10
Each specimens from additionally dissected area
were named as cervical, aortopulmonary window,
lateral of phrenic nerve, and posterior brachioce-
phalic vein for evaluation of ectopic thymic tissue
distribution. Two chest tubes were inserted
through subxiphoid stab incisions, and no separate
drain was inserted at the cervical area. Demo-
graphic and clinico-pathologic data such as age,
gender, body surface area (BSA), Myasthenia
Gravis Foundation of America (MGFA) preopera-
tive clinical classification, acetylcholine receptor
binding antibody titer, thymic pathology, presence
of ectopic thymic tissue, operation time, duration
of intensive care, amount of cumulative drainage,
duration of drainage, decrease of hemoglobin
count, amount of transfusion required, post-
operative hospital stay, and complications were
obtained by a retrospective review of medical
records. In 14 non-thymomatous MG patients in
the TSMT group, the presence of ectopic thymic
tissue outside the extended thymectomy field was
evaluated microscopically with hematoxylin-eosin
staining. All specimens were embedded in paraffin
block after fixed in 10% formalin solution for 3
days, and each 50 micrometer-thick tissue section
at 450 micrometer interval was stained for evalua-
tion. This study was approved by the local institu-
tional review board.
Categorical variables were compared by the  2
or Fisher's exact tests. Unpaired t-test was used for
the comparison of continuous variables. P values
less than 0.05 were considered statistically signifi-
cant. All statistical analyses were performed with
Statistical Package for Social Science (SPSS 12.0,
Chicago, IL, USA).
RESULTS
Out of 24 patients who underwent TSMT, 18
(75%) were female and their mean age was 36.0
years. There was no statistical difference in age,
gender distribution, BSA, acetylcholine receptor
binding antibody titer, or preoperative MGFA
clinical classification between TSMT and TSET
groups. The proportion of patients with thymo-
matous MG was higher in the TSMT group (p =
0.046), but the incidence of follicular hyperplasia
and atrophy were not significantly different (Table
1).
Surgical outcomes
The operative time, duration of chest tube
drainage, and amount of cumulative drainage
were increased in the TSMT group. However, the
range of hemoglobin count decrease, duration of
intensive care, and post-operative hospital stay
were not different between the 2 groups (Table 2).
In the TSET group, 1 case of chylothorax and 1
case of postoperative bleeding requiring re-
operation developed. In the TSMT group, 1 patient
experienced left vocal cord palsy due to an injury
to the cervical recurrent laryngeal nerve. There
was no injury to the recurrent laryngeal nerve at
the aortopulmonary window and phrenic nerves.
No operation-related mortality occurred in either
group.
Ectopic thymic tissue
Of 14 patients evaluated for the presence of
ectopic thymic tissue, 7 (50%) had ectopic thymic
tissues outside the TSET fields. All of these 7
patients had ectopic thymic tissues in the cervical
area (Fig. 1). Ectopic thymic tissues were widely
distributed in cervical area. The proportions of
ectopic thymic tissue positive sections to adipose
tissue section examined are shown in Table 3. Two
patients had additional ectopic thymic tissue at the
aortopulmonary window, and proportions of
positive section to tissue section examined in these
patients were 2/7 and 3/4, respectively. One
patient had ectopic thymic tissue at posterior of
the left brachiocephalic vein (2/5) and lateral of
the right phrenic nerve (3/7).
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DISCUSSION
This study revealed that TSMT is more effective
in the extirpation of ectopic thymic tissues than
TSET especially in the cervical area without
significant increase of morbidity and mortality.
Maximal thymectomy is considered to be an ideal
thymectomy.
4,8
However, there are few reports
about this procedure. Many surgeons are not
willing to perform maximal thymectomy, because
of the belief that the procedure carries a higher rate
of morbidity without definitive evidence of pro-
mising long-term neurologic outcomes compared
with extended thymectomy.6,11,12 TSET had been
used to be the procedure of choice at our clinic,
because it is easy, safe and effective.
11,12
Complete
stable remission (symptom free without medical
treatment for more than 1 year) rates of non-
thymomatous MG were 29.6% at 5 years and 45.2%
at 10 years.5 Since June 2006, however, we have
performed TSMT to increase the rate of ectopic
thymic tissue removal by extending the thymec-
tomy field. TSMT was first introduced as an
anterior-superior cervicomediastinal exenteration
Table 1. Demographic, Clinical and Pathologic Characteristics of the Patients
Characteristics
TSMT (n = 24) TSET (n = 73)
n % n %
Gender
Male 6 25 21 8.8
Female 18 75 52 71.2
Age (yrs) 35.9 ± 13.1 35.2 ± 12.3
BSA (m2) 1.63 ± 0.13 1.65 ± 0.16
Seropositive MG 24 100 58 93.5*
AchR Ab (nmol/L) 9.158 ± 4.946 8.187 ± 5.363
MGFA clinical classification
I 3 12.5 12 16.4
II 16 66.7 49 67.1
III 4 16.7 10 13.6
IV 1 4.2 2 2.8
V 0 0 0 0
Thymic pathology
Normal 4 16.7 8 11.0
Follicular hyperplasia 14 58.3 54 73.9
Atrophy 6 25 11 15.1
Thymoma 9 37.5 13 17.8
Masaoka stage I 8 33.3 6 8.2
II 1 4.2 7 9.6
TSMT, transsternal maximal thymectomy; TSET, transsternal extended thymectomy, BSA, body surface area; AchR Ab,
acetylcholine receptor binding antibody; MGFA, Myasthenia Gravis Foundation of America.
Plus-minus values are mean ± SD.
*The percentage of this category is calculated by dividing the number of seropositive patients (58) into number of patients
(62) with available data.
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by Chen and colleagues.
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Difference between this
technique and transcervical trans-sternal maximal
thymectomy is that cervical dissection is perfor-
med under the cervical flap after a full-length
midsternotomy without transverse cervical inci-
sion. By this method, almost all cervico-mediasti-
nal adipose tissues can be extirpated. Two main
concerns about maximal thymectomy are surgical
safety and clinical efficacy. In terms of safety,
surgical outcomes of this study indicate that TSMT
does not have a higher rate of morbidity and
mortality than extended thymectomy. Although
TSMT increased operation time, cumulative
drainage, and days of chest tube maintenance, the
overall recovery and complication rates were not
significantly different from TSET. Increased cumu-
Table 2. Comparison of Surgical Outcomes
Variables TSMT TSET p value
Operation time (min) 137 ± 27 108 ± 23 0.00
Cumulative Drainage (mL) 1,123 ± 691 714 ± 493 0.002
Duration of Drainage (day) 5.1 ± 1.7 4.2 ± 1.7 0.03
Hemoglobin decrease (g/dL) 2.35 ± 1.18 2.31 ± 1.66 0.93
Transfused packed RBC (unit) 0.12 ± 0.57 0.17 ± 0.47 0.41
Duration of intensive care (day)* 2 (1 - 28) 3 (1 - 13) 0.61
Duration of hospital stay (day)* 9 (5 - 90) 10 (5 - 300) 0.81
TSMT, transsternal maximal thymectomy; TSET, transsternal extended thymectomy; RBC, red blood cell.
Plus-minus values are mean ± SD.
*median (range).
Table 3. Proportion of the Number of Ectopic Thymic Tissue Positive Section to the Number of Total Cervical Adipose
Tissue Section
Patient No. Total (n) Positive (n) Proportion (%)
1 10 1 10
2 8 1 13
3 8 4 50
4 10 6 60
5 13 13 100
6 8 8 100
7 6 6 100
Total 63 39 62
Fig. 1. Low power view of the ectopic thymus in cervical
adipose tissue showing germinal centers in the medulla
(hematoxylin-eosin, × 40).
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lative drainage and prolonged chest tube main-
tenance in TSMT might be due to more extended
field of dissection than TSET. Different proportion
of thymoma patients between 2 groups might not
be influenced by the amount and duration of
drainage and chest tube. Because all thymomas
were in Masaoka stage I or II and thymoma itself
did not complicate the procedure. No operation-
related mortality occurred in either group. The
most dreaded complication of maximal thymec-
tomy is functional impairment due to nerve injury.
One episode of recurrent laryngeal nerve injury
developed in a second patient in this series. No
more recurrent nerve injury occurred thereafter.
Recurrent laryngeal nerve injury at the cervical
area in that patient might be a technical failure due
to unfamiliar approach method. However, this
could be overcome in a short time because cervical
dissection and preservation of recurrent laryngeal
nerves through cervical incision are familiar pro-
cedures through the experience about surgical
treatment of esophageal disease, tracheal disease,
and other cervical diseases. There was no injury
to the phrenic nerves or recurrent laryngeal nerve
at the aortopulmonary window. Dissection of the
phrenic nerve and left recurrent laryngeal nerve
at the aortopulmonary window is also a familiar
procedure for thoracic surgeons who perform
systematic lymph node dissections in lung cancer
surgery, and can safely be done. A few studies of
maximal thymectomy also reported no thymec-
tomy-related mortality and low complication rates.
Jaretzki and colleagues reported no mortality and
a 4.5% complication rate in 157 patients after
maximal thymectomy. Almost all their complica-
tions were wound-related, and only 1 case of
chylothorax was attributed specifically to maximal
thymectomy.13 Ashour and colleagues also reported
two cases of re-exploration due to postoperative
bleeding, 6 cases of pulmonary complications, and
2 cases of septicemia in 48 patient without any
mortality.14 In the following report, however, they
experienced no complications in 30 pediatric
patients.15 Both authors reported no recurrent
laryngeal or phrenic nerve injury. Zielińsky and
colleagues reported only 1 case of temporary
recurrent laryngeal nerve injury in 100 patients
who underwent maximal cervical dissection.
4
Although the incidence and distribution of ectopic
thymic tissues varies, the presence of ectopic
thymic tissue is evident.4,16,17 Theoretically, a more
radical resection of ectopic thymic tissue results in
a larger decrease in the antigenic focus for auto-
immune disease, therefore maximal thymectomy is
regarded as the most effective method of thymec-
tomy.4,8 Some studies have provided more
promising results.8,15 However, comparison of the
prognostic value of various methods of thymec-
tomy is difficult at present, because almost all
these studies were conducted in a retrospective
setting and used subjective parameters for end
points with inappropriate statistical analysis
methods.2,8 Furthermore, no prospective rando-
mized studies have been reported. The efficacy of
ectopic thymic tissue removal appeared to be a
useful indirect indicator for the long-term neurologic
efficacy of TSMT in a short time. Ectopic thymic
tissues embedded in the aortopulmonary window,
lateral to the phrenic nerves, and posterior to the
left brachiocephalic vein could additionally be
removed in 21% of patients by TSMT. The most
significant finding of this study is that extirpation
of cervical adipose tissues through TSMT is essen-
tial, because 50% of patients have a chance of
having residual thymic tissue in the cervical area
after TSET. Moreover, the burden of residual
thymic tissue in cervical area is also considerable.
The reported prevalence of ectopic thymic tissue
in the cervical area is 10 to 63%.3,4,17 The impor-
tance of extirpation of cervical adipose tissues can
also be recognized through experiences with trans-
cervical thymectomy. Comparable clinical out-
comes with transcervical thymectomy indicate that
the burden of ectopic tissue in the cervical area is
not insignificant, compared with the lower
mediastinal area.6,18,19 Thus, extirpation of cervical
adipose tissue must be considered as a routine
aspect of thymectomy, since it is in lower medi-
astinum and the TSMT is one of ideal approachs
for thymectomy.
Recently, interest in minimally invasive thymec-
tomy has increased.4,7,20 From our results, we can
recommend that, in minimally invasive thymec-
tomy, a bilateral approach to dissection of the
lateral area of each phrenic nerve and the aorto-
pulmonary window with separate cervical dis-
section is an ideal method for radical removal of
thymic tissues.
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A limitation of this study is a small number of
study subjects and short study time, which suggest
the need for a large-volume study and estimation
of neurologic outcomes. At present, it is impossible
to predict how many patients will get more clinical
benefit by TSMT. Furthermore, no extra ectopic
tissue was found in 50% of patients with TSMT
in this study. Therefore, the benefit and risk of
TSMT might be estimated by further long-term
study. Another limitation is that this study pro-
vided no information about the quantitative
analysis of ectopic thymic tissues and the pro-
portion of additionally removed ectopic thymic
tissues to the whole burden of thymic tissue. This
information might be more representative of the
improvement of outcomes. In conclusion, TSMT is
effective and feasible method for the treatment of
myasthenia gravis, and extirpation of cervical
adipose tissues must be incorporated into the
standard procedure of thymectomy.
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